Aehr Test Systems Director Rhea Posedel Sells 5,973 Shares

What Happened

• Rhea J. Posedel, a director of Aehr Test Systems (AEHR), sold 5,973 shares on August 14, 2026. The shares were sold at $140.00 each, producing gross proceeds of approximately $836,220. The transaction is reported as a sale (S) and listed as an open-market or private sale.

Key Details

• Transaction date and price: Aug 14, 2026 — 5,973 shares at $140.00 per share.
• Total value: ~ $836,220 (gross proceeds).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: F1 states the reported amount includes shares subject to unvested restricted stock units (RSUs).
• Filing timeliness: Period of report and filing date are both Aug 14, 2026, so the filing appears to be timely. No 10b5-1 plan or other trading-plan language is indicated in the excerpt.

Context

• This was a sale, which is often routine (e.g., portfolio rebalancing or tax-related) and does not by itself indicate management sentiment about the company. The footnote noting inclusion of unvested RSUs means some of the reported shares relate to awards not yet vested, which can affect how the holding change is interpreted. For many investors, insider purchases are more informative than isolated sales.